Medicines shortages are a problem for many European countries. Now is the time to act, to save the availability of critical generic medicines for patients across the region.
Read Teva’s Report and RecommendationsAn analysis of generic medicine supply challenges, and the need to protect patient access
Explore the 2024 reportIn this report, we explore how a policy framework can help sustain the pharmaceutical ecosystem in Europe and ensure the critical and affordable supply of essential high-quality medicines to European patients for years to come.
This information is intended for a European audience.